About Index Trending news
Analyze
Top 50 Pricing
Theravance

Theravance

Work at Theravance? Add yourself to this profile

Theravance

Theravance develops small molecule medicines for respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Elsewhere

Alexa global traffic share

Latest funding
Private equity
$129,375,000
Employees

Team size

200+
The Motley Fool

Why Theravance Inc. Vaulted 15% Higher in October --

Stock markets Earnings
The Motley Fool

Theravance Biopharma Inc Skyrocketed in October -- Here's Why --

Stock markets Health